Differential effects of ginsenoside metabolites on slowly activating delayed rectifier K+ and KCNQ1 K+ channel currents |
Choi, Sun-Hye
(Ginsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine and Bio/Molecular Informatics Center, Konkuk University)
Lee, Byung-Hwan (Ginsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine and Bio/Molecular Informatics Center, Konkuk University) Kim, Hyeon-Joong (Ginsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine and Bio/Molecular Informatics Center, Konkuk University) Jung, Seok-Won (Ginsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine and Bio/Molecular Informatics Center, Konkuk University) Hwang, Sung-Hee (Department of Pharmaceutical Engineering, Sangji University) Nah, Seung-Yeol (Ginsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine and Bio/Molecular Informatics Center, Konkuk University) |
1 | Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996;12:17-23. DOI ScienceOn |
2 | Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996;384:78-80. DOI ScienceOn |
3 | Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, Keating MT. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 1996;384:80-83. DOI ScienceOn |
4 | Pusch M, Magrassi R, Wollnik B, Conti F. Activation and inactivation of homomeric KvLQT1 potassium channels. Biophys J 1998;75:785-792. DOI ScienceOn |
5 | Seebohm G, Scherer CR, Busch AE, Lerche C. Identification of specific pore residues mediating KCNQ1 inactivation. A novel mechanism for long QT syndrome. J Biol Chem 2001;276:13600-13605. DOI |
6 | Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997;15:186-189. DOI ScienceOn |
7 | Mall M, Bleich M, Schurlein M, Kuhr J, Seydewitz HH, Brandis M, Greger R, Kunzelmann K. Cholinergic ion secretion in human colon requires coactivation by cAMP. Am J Physiol 1998;275(6 Pt 1):G1274- G1281. |
8 | Grahammer F, Herling AW, Lang HJ, Schmitt-Graff A, Wittekindt OH, Nitschke R, Bleich M, Barhanin J, Warth R. The cardiac channel KCNQ1 is essential for gastric acid secretion. Gastroenterology 2001;120:1363-1371. DOI ScienceOn |
9 | Snyders DJ. Structure and function of cardiac potassium channels. Cardiovasc Res 1999;42:377-390. DOI ScienceOn |
10 | Cheng JH, Kodama I. Two components of delayed rectifier K+ current in heart: molecular basis, functional diversity, and contribution to repolarization. Acta Pharmacol Sin 2004;25:137-145. |
11 | Sanguinetti MC. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia. Ann N Y Acad Sci 1999;868:406-413. DOI |
12 | Roden DM, Balser JR, George AL Jr, Anderson ME. Cardiac ion channels. Annu Rev Physiol 2002;64:431-475. DOI ScienceOn |
13 | Tristani-Firouzi M, Sanguinetti MC. Structural determinants and biophysical properties of HERG and KCNQ1 channel gating. J Mol Cell Cardiol 2003;35:27-35. DOI ScienceOn |
14 | Robbins J. KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol Ther 2001;90:1-19. DOI ScienceOn |
15 | Nah SY. Ginseng: recent advances and trends. Korea J Ginseng Sci 1997;21:1-12. 과학기술학회마을 |
16 | Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-1693. DOI ScienceOn |
17 | Chen X, Gillis CN, Moalli R. Vascular effects of ginsenosides in vitro. Br J Pharmacol 1984;82:485-491. DOI ScienceOn |
18 | Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 1996;23:728-732. DOI ScienceOn |
19 | Furukawa T, Bai CX, Kaihara A, Ozaki E, Kawano T, Nakaya Y, Awais M, Sato M, Umezawa Y, Kurokawa J. Ginsenoside Re, a main phytosterol of Panax ginseng, activates cardiac potassium channels via a nongenomic pathway of sex hormones. Mol Pharmacol 2006;70:1916-1924. DOI ScienceOn |
20 | Bai CX, Sunami A, Namiki T, Sawanobori T, Furukawa T. Electrophysiological effects of ginseng and ginsenoside Re in guinea pig ventricular myocytes. Eur J Pharmacol 2003;476:35-44. DOI ScienceOn |
21 | Choi SH, Shin TJ, Lee BH, Chu DH, Choe H, Pyo MK, Hwang SH, Kim BR, Lee SM, Lee JH et al. Ginsenoside Rg3 activates human KCNQ1 channel currents through interacting with the K318 and V319 residues: a role of KCNE1 subunit. Eur J Pharmacol 2010;637:138-147. DOI ScienceOn |
22 | Choi SH, Shin TJ, Hwang SH, Lee BH, Kang J, Kim HC, Oh JW, Bae CS, Lee SH, Nah SY. Differential effects of ginsenoside metabolites on HERG channel currents. J Ginseng Res 2011;35:191-199. 과학기술학회마을 DOI ScienceOn |
23 | Hasegawa H, Suzuki R, Nagaoka T, Tezuka Y, Kadota S, Saiki I. Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol. Biol Pharm Bull 2002;25:861-866. DOI ScienceOn |
24 | Akao T, Kanaoka M, Kobashi K. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration: measurement of compound K by enzyme immunoassay. Biol Pharm Bull 1998;21:245-249. DOI ScienceOn |
25 | Bae EA, Park SY, Kim DH. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull 2000;23:1481-1485. DOI ScienceOn |
26 | Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos 2003;31:1065-1071. DOI ScienceOn |
27 | Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 1997;17:338-340. DOI ScienceOn |
28 | Lee JH, Jeong SM, Kim JH, Lee BH, Yoon IS, Lee JH, Choi SH, Kim DH, Rhim H, Kim SS et al. Characteristics of ginsenoside Rg3-mediated brain current inhibition. Mol Pharmacol 2005;68:1114-1126. DOI ScienceOn |
29 | Wakabayashi C, Hasegawa H, Murata J, Saiki I. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol Res 1997;9:411-417. |
30 | Wang CZ, Du GJ, Zhang Z, Wen XD, Calway T, Zhen Z, Musch MW, Bissonnette M, Chang EB, Yuan CS. Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer. Int J Oncol 2012;40:1970-1976. |
31 | Seebohm G, Pusch M, Chen J, Sanguinetti MC. Pharmacological activation of normal and arrhythmia-associated mutant KCNQ1 potassium channels. Circ Res 2003;93:941-947. DOI ScienceOn |
32 | Salata JJ, Jurkiewicz NK, Wang J, Evans BE, Orme HT, Sanguinetti MC. A novel benzodiazepine that activates cardiac slow delayed rectifier currents. Mol Pharmacol 1998;54:220-230. DOI |
33 | Lee JH, Jeong SM, Kim JH, Lee BH, Yoon IS, Lee JH, Choi SH, Lee SM, Park YS, Lee JH et al. Effects of ginsenosides and their metabolites on voltage-dependent Ca(2+) channel subtypes. Mol Cells 2006;21:52-62. 과학기술학회마을 |
34 | Kim JH, Hong YH, Lee JH, Kim DH, Nam G, Jeong SM, Lee BH, Lee SM, Nah SY. A role for the carbohydrate portion of ginsenoside Rg3 in channel inhibition. Mol Cells 2005;19:137-142. 과학기술학회마을 |
35 | Shin TJ, Hwang SH, Choi SH, Lee BH, Kang J, Kim HJ, Zukin RS, Rhim H, Nah SY. Effects of protopanaxatriol-ginsenoside metabolites on rat N-methyl-d-aspartic acid receptor-mediated ion currents. Korean J Physiol Pharmacol 2012;16:113-118. 과학기술학회마을 DOI ScienceOn |